penimocycline: obtained by Mannich reaction between tetracycline & ampicillin; structure
ID Source | ID |
---|---|
PubMed CID | 76972772 |
CHEMBL ID | 3989414 |
MeSH ID | M0056963 |
Synonym |
---|
penimocycline |
penimocyclinum |
einecs 240-365-5 |
penimociclina |
6-(2-(((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)amino)-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid |
penimociclina [inn-spanish] |
penimocycline [inn:dcf] |
2176o1m292 , |
16259-34-0 |
penimocyclinum [inn-latin] |
6-(((((((4-(dimethylamino)-1,4alpha,4aalpha,5,5aalpha,6beta,11,12aalpha-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl)carbonyl)amino)methyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxyl |
unii-2176o1m292 |
penimocycline [inn] |
CHEMBL3989414 |
(2s,5r,6r)-6-[[(2r)-2-[[[(4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxy |
Q27253527 |
DTXSID601043146 |
Penimocycline is an antibiotic obtained by Mannich reaction between tetracycline and ampicilline.
Excerpt | Reference | Relevance |
---|---|---|
"Penimocycline is an antibiotic obtained by Mannich reaction between tetracycline and ampicilline. " | ( [High-performance liquid chromatography of penimocycline (author's transl)]. Bollet, C; Caude, M; Chevalier, G; Risse, C; Rohrbach, P; Rosset, R, 1976) | 1.96 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |